The company shines a light on data-driven insights and their award-winning Insurance Discovery tool on healthcare's biggest stage CHICAGO, April 17, 2023 /PRNewswire/ -- FinThrive, Inc.™, a...

BridGene Biosciences, Inc., a biotechnology company using a proprietary chemoproteomics technology to discover and develop small molecules for high-value, traditionally undruggable targets,...

This workflow revolutionizes immunotherapy research and development by comprehensively profiling single T cells to correlate polyfunctionality with cytotoxicity and recovery of those same cells...

- Data to be presented at American Association for Cancer Research (AACR) Annual Meeting 2023 - MARLBOROUGH, Mass., April 17, 2023 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a...

Bringing together Bio-Techne's gold standard RNAscope™ technology with Lunaphore's multiplex sequential immunofluorescence (seqIF™) COMET™ system to develop a best-in-class end-to-end...